TY - JOUR
T1 - Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways
AU - Pysher, Michele D.
AU - Chen, Qin M.
AU - Vaillancourt, Richard R.
N1 - Funding Information:
This work was supported, in part, by ES04940, ES12007, AG19710 (R.R.V.). M.D.P. was supported by a postdoctoral fellowship from the Interdisciplinary Physiological Sciences Program at the University of Arizona (National Institutes of Health Training Grant HL07249). We thank Suzanne Regan for her assistance with VSMCs.
PY - 2008/9/1
Y1 - 2008/9/1
N2 - Chronic exposure to arsenic has been linked to tumorigenesis, cardiovascular disease, hypertension, atherosclerosis, and peripheral vascular disease; however, the molecular mechanisms underlying its pathological effects remain elusive. In this study, we investigated arsenic-induced alteration of focal adhesion protein complexes in normal, primary vascular smooth muscle cells. We demonstrate that exposure to environmentally relevant concentrations of arsenic (50 ppb As3+) can alter focal adhesion protein co-association leading to activation of downstream pathways. Co-associated proteins were identified and quantitated via co-immunoprecipitation, SDS-PAGE, and Western blot analysis followed by scanning densitometry. Activation of MAPK pathways in total cell lysates was evaluated using phosphor-specific antibodies. In our model, arsenic treatment caused a sustained increase in FAK-src association and activation, and induced the formation of unique signaling complexes (beginning after 3-hour As3+ exposure and continuing throughout the 12-hour time course studied). The effects of these alterations were manifested as chronic stimulation of downstream PAK, ERK and JNK pathways. Past studies have demonstrated that these pathways are involved in cellular survival, growth, proliferation, and migration in VSMCs.
AB - Chronic exposure to arsenic has been linked to tumorigenesis, cardiovascular disease, hypertension, atherosclerosis, and peripheral vascular disease; however, the molecular mechanisms underlying its pathological effects remain elusive. In this study, we investigated arsenic-induced alteration of focal adhesion protein complexes in normal, primary vascular smooth muscle cells. We demonstrate that exposure to environmentally relevant concentrations of arsenic (50 ppb As3+) can alter focal adhesion protein co-association leading to activation of downstream pathways. Co-associated proteins were identified and quantitated via co-immunoprecipitation, SDS-PAGE, and Western blot analysis followed by scanning densitometry. Activation of MAPK pathways in total cell lysates was evaluated using phosphor-specific antibodies. In our model, arsenic treatment caused a sustained increase in FAK-src association and activation, and induced the formation of unique signaling complexes (beginning after 3-hour As3+ exposure and continuing throughout the 12-hour time course studied). The effects of these alterations were manifested as chronic stimulation of downstream PAK, ERK and JNK pathways. Past studies have demonstrated that these pathways are involved in cellular survival, growth, proliferation, and migration in VSMCs.
KW - Arsenic
KW - FAK
KW - Focal adhesion
KW - Src
KW - Vascular smooth muscle cell
UR - http://www.scopus.com/inward/record.url?scp=49549110251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49549110251&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2008.04.002
DO - 10.1016/j.taap.2008.04.002
M3 - Article
C2 - 18486177
AN - SCOPUS:49549110251
SN - 0041-008X
VL - 231
SP - 135
EP - 141
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 2
ER -